AMITRIPTYLINE for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 14 adverse event reports in the FDA FAERS database where AMITRIPTYLINE was used for Psoriasis.
Most Reported Side Effects for AMITRIPTYLINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Toxicity to various agents | 3,001 | 14.7% | 1,724 | 1,288 |
| Drug ineffective | 2,344 | 11.5% | 59 | 525 |
| Completed suicide | 1,678 | 8.2% | 1,672 | 446 |
| Off label use | 1,588 | 7.8% | 72 | 435 |
| Pain | 1,300 | 6.4% | 71 | 690 |
| Fall | 1,216 | 6.0% | 31 | 943 |
| Hypotension | 1,205 | 5.9% | 103 | 984 |
| Drug abuse | 1,116 | 5.5% | 674 | 300 |
| Dizziness | 1,041 | 5.1% | 77 | 339 |
| Constipation | 1,035 | 5.1% | 17 | 696 |
| Nausea | 1,018 | 5.0% | 40 | 305 |
| Fatigue | 1,014 | 5.0% | 50 | 296 |
| Overdose | 1,009 | 5.0% | 327 | 606 |
| Sedation | 975 | 4.8% | 37 | 567 |
| Product use in unapproved indication | 868 | 4.3% | 27 | 229 |
Other Indications for AMITRIPTYLINE
Product used for unknown indication (9,543)
Depression (1,410)
Pain (752)
Neuralgia (651)
Migraine (619)
Insomnia (614)
Sleep disorder (232)
Fibromyalgia (224)
Headache (220)
Migraine prophylaxis (185)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)